| New Risks for Some Stomach Drugs Medications known as proton pump inhibitors, which suppress acid in the stomach, appear to be associated with fractures in postmenopausal women and with higher rates of bacterial infections. online.wsj.com |
U.K. Approves Botox for Migraines Allergan said the U.K.'s drug regulator became the first in the world to approve Botox as a tool for preventing chronic migraine headaches. online.wsj.com |
Bruker Corp. Q2 2010 Earnings Call Transcript Bruker Corp. (BRKR)Q2 2010 Earnings Conference Call July 28, 2010 10:00 am ETComplete Story » seekingalpha.com |
NuPathe Trades at Discount to IPO Price with Near-Term FDA Filing Mike Havrilla submits:NuPathe (NASDAQ:PATH) completed its initial public offering (IPO) on 8/6/10 at $10 per share for 5 million shares of common stock, raising $43 million in net proceeds. The Company's stock is currently trading at a 20% discount at $8 per share with a market cap of $116 million and expects to submit a New Drug Application (NDA) through the 505(b)(2) pathway, representing a novel formulation of a previously approved drug compound.NuPathe ended 2Q10 with $51.5 million in cash/equivalents, which includes net proceeds received from the IPO in early August. The Company reported a net loss of $5.6 million during 2Q10, including $3.3 million for research & development (R&D).Complete Story » seekingalpha.com |
Justices Wrestle With Vaccine Case The Supreme Court wrestled with the potential consequences of a case that asks the justices to decide whether federal law shields vaccine makers from some types of product-liability lawsuits. online.wsj.com |